ArticleDrug and alcohol review2026
Perceived Prescription Opioid and Medical Cannabis-Related Stigma Among US Adults With and Physicians Who Treat Chronic Pain.
Article in Drug and alcohol review, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
introductionStigma may influence prescription opioid and cannabis use for pain management among people experiencing and physicians treating chronic pain. We assessed differences in perceived stigma around prescription opioids and cannabis for chronic pain among these two groups.
methodsData were from surveys of adults with chronic pain and physicians in 36 states and DC with medical cannabis laws, administered in March-April 2022 and July-August 2023, respectively. Stigma was measured as whether respondents believed they would be treated unfairly by neighbours, family or employers if using prescription opioids/cannabis for chronic pain. We compared survey-weighted estimates of perceived prescription opioid and cannabis stigma between patients and physicians using chi-squared tests and developed stigma scales (range: 1 [low stigma]-5 [high stigma]) to compare average stigma scores for each substance within subgroups.
resultsCompared to adults with chronic pain, physicians were more likely to believe they would be treated unfairly for managing chronic pain with prescription opioids by neighbours (39.3% vs. 18.4%, p value < 0.001), family (32.8% vs. 17.4%, p value < 0.001) and employers (49.8% vs. 29.8%, p value < 0.001). Findings were consistent for cannabis. Prescription opioid stigma scores were lower than cannabis scores among adults with chronic pain (2.73 vs. 2.83) and physicians (3.22 vs. 3.33). DISCUSSION AND
conclusionsRelative to adults with chronic pain, physicians were more likely to perceive stigma around prescription opioid or cannabis use. Both perceived more stigma associated with cannabis than prescription opioids for pain management. Group differences may reflect clinical guidance around opioid and cannabis for chronic pain, and substance differences may reflect cannabis's federal illegality.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.